analiza aiqbench
This study leverages LightGBM models to analyze longitudinal biomarker trajectories within the All of Us Research Program, demonstrating their ability to predict functional decline in older adults up to a year before clinical onset. By utilizing routine laboratory data already present in electronic health records, the approach offers a zero-burden method for early detection that outperforms static summaries. The research highlights the practical application of machine learning in identifying pre-clinical phases of mobility loss using existing healthcare infrastructure.
Predicting Early Functional Decline from Longitudinal Laboratory and Vital Sign Trajectories: A Large-Scale Study Using the All of Us Research Program
arXiv:2608.21589v1 Announce Type: new Abstract: Functional decline in older adults is typically recognized only after falls or observable gait impairment, closing the window for prevention. We investigated whether temporal trajectories of routine biomarkers, already recorded but rarely analyzed longitudinally, can identify patients in the pre-clinical phase of mobility decline. Using the All of Us Research Program (N = 297,861; 11.1% cases), we derived trajectory features (slope, variability, delta, mean) for twelve biomarkers over a three-year pre-index window. LightGBM models incorporating trajectories significantly outperformed static laboratory summaries (AUROC 0.797 vs. 0.755; DeLong p < 0.001; AUPRC 0.380 vs. 0.304). A 1:1 age- and sex-matched analysis confirmed an independent trajectory signal (AUROC 0.727 vs. demographics-only 0.680). A horizon analysis demonstrated sustained prediction 3-12 months before decline onset (AUROC 0.768-0.740). Because the model uses only measurements already ordered in routine care, it supports passive, zero-burden EHR integration for early detection of pre-clinical functional decline.
Abstract:Functional decline in older adults is typically recognized only after falls or observable gait impairment, closing the window for prevention. We investigated whether temporal trajectories of routine biomarkers, already recorded but rarely analyzed longitudinally, can identify patients in the pre-clinical phase of mobility decline. Using the All of Us Research Program (N = 297,861; 11.1% cases), we derived trajectory features (slope, variability, delta, mean) for twelve biomarkers over a three-year pre-index window. LightGBM models incorporating trajectories significantly outperformed static laboratory summaries (AUROC 0.797 vs. 0.755; DeLong p < 0.001; AUPRC 0.380 vs. 0.304). A 1:1 age- and sex-matched analysis confirmed an independent trajectory signal (AUROC 0.727 vs. demographics-only 0.680). A horizon analysis demonstrated sustained prediction 3-12 months before decline onset (AUROC 0.768-0.740). Because the model uses only measurements already ordered in routine care, it supports passive, zero-burden EHR integration for early detection of pre-clinical functional decline.
Machine Learning (cs.LG); Applications (stat.AP)
arXiv:2608.21589 [cs.LG]
(or arXiv:2608.21589v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2608.21589 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Text integral sub licența deschisă a publicației · 242 cuvinte
Subiecte conexe

[AINews] not much happened today
Latent Space · 3 oct. 2026

BRICS Draws a New Global Line: Full Text of New Delhi Declaration
slguardian.org · 12 sept. 2026

XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · 19 aug. 2026
Introducing SynthID Bio
Google DeepMind · 30 sept. 2026